Humog 150 IU

Humog 150 IU by Bharat Serums and Vaccines Ltd. (BSV) is a pharmaceutical-grade, highly purified injectable gonadotropin formulation containing Human Menopausal Gonadotropin (hMG). Each lyophilized vial delivers a balanced ratio of 150 IU of Follicle-Stimulating Hormone (FSH) and 150 IU of Luteinizing Hormone (LH) activity. Manufactured by BSV under rigid Good Manufacturing Practice (GMP) standards, Humog 150 IU offers maximum biological potency, exact unit standardization, and high purity.

In clinical endocrinology and reproductive medicine, Humog is prescribed to stimulate spermatogenesis in hypogonadal men and induce follicular development in female fertility protocols. In performance, bodybuilding, and post-cycle recovery contexts, Humog 150 IU is widely recognized as the ultimate therapeutic compound for restoring full spermatogenesis (sperm production), testicular size, and natural fertility that has been severely compromised by prolonged anabolic steroid or hormonal suppressor cycles.

Key Benefits & Applications

• Dual Pituitary Hormone Simulation: Unlike hCG (which only mimics LH), Humog delivers both FSH and LH, simultaneously driving Leydig cell steroidogenesis and Sertoli cell spermatogenesis.

• Direct Spermatogenesis Activation: FSH is mandatory for triggering and maintaining active sperm production, making Humog the gold standard for restoring fertility and sperm count after severe hormonal suppression.

• Complete Testicular Restoration: Fully restores both structural compartments of the testes—the interstitial Leydig cells (testosterone production) and the seminiferous tubules (which make up $\sim 80\%$ of total testicular volume).

• Enhanced PCT & Recomp Recovery: Provides a complete endocrine bridge during advanced Post Cycle Therapy (PCT) or fertility protocols when hCG alone fails to restore testicular function or sperm motility.

• High Purification Standards: Advanced biological purification reduces extraneous protein impurities, minimizing local skin sensitivity or injection site reactions.